MediciNova Inc
NASDAQ:MNOV
Balance Sheet
Balance Sheet Decomposition
MediciNova Inc
Current Assets | 51.2m |
Cash & Short-Term Investments | 51m |
Other Current Assets | 174.9k |
Non-Current Assets | 15.1m |
PP&E | 621.2k |
Intangibles | 14.4m |
Other Non-Current Assets | 74.2k |
Current Liabilities | 3.3m |
Accounts Payable | 1m |
Accrued Liabilities | 2.3m |
Non-Current Liabilities | 612.5k |
Other Non-Current Liabilities | 612.5k |
Balance Sheet
MediciNova Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
12
|
22
|
24
|
28
|
62
|
64
|
60
|
71
|
19
|
51
|
|
Cash Equivalents |
12
|
22
|
24
|
28
|
62
|
64
|
60
|
71
|
19
|
51
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
Total Current Assets |
12
|
23
|
25
|
28
|
63
|
64
|
61
|
72
|
59
|
51
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Accumulated Depreciation |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
Intangible Assets |
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
Goodwill |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
Long-Term Investments |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
Total Assets |
27
N/A
|
38
+39%
|
40
+5%
|
43
+9%
|
77
+78%
|
79
+3%
|
75
-5%
|
87
+16%
|
74
-15%
|
66
-11%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
0
|
0
|
2
|
1
|
1
|
1
|
0
|
0
|
1
|
|
Accrued Liabilities |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
2
|
2
|
2
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Deferred Income Tax |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
|
Total Liabilities |
5
N/A
|
5
-2%
|
5
+2%
|
5
-9%
|
4
-15%
|
4
+5%
|
4
-5%
|
4
-10%
|
4
+5%
|
4
0%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
311
|
319
|
330
|
342
|
356
|
369
|
383
|
393
|
407
|
416
|
|
Additional Paid In Capital |
333
|
352
|
365
|
380
|
429
|
444
|
454
|
477
|
477
|
478
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
22
N/A
|
33
+49%
|
35
+5%
|
39
+12%
|
73
+89%
|
75
+2%
|
71
-5%
|
84
+17%
|
70
-16%
|
62
-11%
|
|
Total Liabilities & Equity |
27
N/A
|
38
+39%
|
40
+5%
|
43
+9%
|
77
+78%
|
79
+3%
|
75
-5%
|
87
+16%
|
74
-15%
|
66
-11%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
24
|
30
|
35
|
37
|
42
|
44
|
45
|
49
|
49
|
49
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|